IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Arch Venture Management, LLC

Q1 2019 Holdings

Filed 2019-05-14 | 6 holdings | $103.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Rubius Therapeutics IncCOM78116T103$47.4K2,618,35145.8%
Kura Oncology Inc(KURA)COM50127T109$26.6K1,606,30725.7%
Fate Therapeutics Inc(FATE)COM31189P102$22.4K1,273,19021.6%
Chiasma Inc(CHMA)COM16706W102$6.2K1,196,7766.0%
Bellerophon Therapeutics, Inc(BLPHEUR)COM078771102$631965,6600.6%
Achaogen IncCOM004449104$285624,5440.3%